- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Hospital Ramón y Cajal](/img/noimage_org.png)
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (118)
2024
-
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response
Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618
-
Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort
Critical Care, Vol. 28, Núm. 1
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Spiritual Care[Givers] Competence in Palliative Care: A Scoping Review
Healthcare (Switzerland), Vol. 12, Núm. 11
-
Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination
Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 223-234
2023
-
Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs
JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403
-
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525
-
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 9, Núm. 2
-
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666
-
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis
The European respiratory journal, Vol. 61, Núm. 3
-
Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 566-574
-
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Patient Preference and Adherence, Vol. 17, pp. 1431-1439
-
Impact of the “Zero Resistance” program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study
Medicina Intensiva, Vol. 47, Núm. 4, pp. 193-202
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Monitoring response to disease-modifying treatment in multiple sclerosis
Neurology Perspectives, Vol. 3, Núm. 2
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study
Neurologia, Vol. 38, Núm. 6, pp. 412-418
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354